Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (151-160 of 518) with videos related to

Pageof 52
Sort By:
Brain : a Journal of Neurology|September 12, 2009
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Clinical Chemistry|June 29, 2002
Biological variation of glycohemoglobinCurt Rohlfing, Hsiao-Mei Wiedmeyer, Randie Little, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2011
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancerJianguo Zhi, Eric Chen, Pierre Major, et al.
Australian Journal of Primary Health|September 9, 2022
Uptake of Team Care Arrangements for adults newly diagnosed with cancerOscar Perez-Concha, David Goldstein, Mark F Harris, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2012
Impact of oxaliplatin-induced neuropathy: a patient perspectiveBarbara K Bennett, Susanna B Park, Cindy S-Y Lin, et al.
Oncotarget|November 5, 2017
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
Oncotarget|December 22, 2016
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivityGeorge Sharbeen, Janet Youkhana, Amanda Mawson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 25, 2024
Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer CenterCarly C Barron, Tyler Pittman, Wei Xu, et al.
Prehospital Emergency Care|April 14, 2022
Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use PilotH Gene Hern, Vanessa Lara, David Goldstein, et al.
Head & Neck|April 3, 2018
Investigation of thyroid nodules: A practical algorithm and review of guidelinesJin Soo A Song, Adam A Dmytriw, Eugene Yu, et al.
Pageof 52

Showing results (151-160 of 518) with videos related to

Sort By:
Pageof 52
Brain : a Journal of Neurology|September 12, 2009
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathySusanna B Park, Cindy S-Y Lin, Arun V Krishnan, et al.
Clinical Chemistry|June 29, 2002
Biological variation of glycohemoglobinCurt Rohlfing, Hsiao-Mei Wiedmeyer, Randie Little, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2011
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancerJianguo Zhi, Eric Chen, Pierre Major, et al.
Australian Journal of Primary Health|September 9, 2022
Uptake of Team Care Arrangements for adults newly diagnosed with cancerOscar Perez-Concha, David Goldstein, Mark F Harris, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2012
Impact of oxaliplatin-induced neuropathy: a patient perspectiveBarbara K Bennett, Susanna B Park, Cindy S-Y Lin, et al.
Oncotarget|November 5, 2017
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
Oncotarget|December 22, 2016
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivityGeorge Sharbeen, Janet Youkhana, Amanda Mawson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 25, 2024
Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer CenterCarly C Barron, Tyler Pittman, Wei Xu, et al.
Prehospital Emergency Care|April 14, 2022
Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use PilotH Gene Hern, Vanessa Lara, David Goldstein, et al.
Head & Neck|April 3, 2018
Investigation of thyroid nodules: A practical algorithm and review of guidelinesJin Soo A Song, Adam A Dmytriw, Eugene Yu, et al.
Pageof 52